Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults

por Lazarus, Rajeka, Taucher, Christian, Brown, Claire, Čorbic Ramljak, Irena, Danon, Leon, Dubischar, Katrin, Duncan, Christopher J.A., Eder-Lingelbach, Susanne, Faust, Saul N., Green, Christopher, Gokani, Karishma, Hochreiter, Romana, Wright, Johanna Kellett, Kwon, Dowan, Middleditch, Alexander, Munro, Alasdair P.S., Naker, Kush, Penciu, Florentina, Price, David, Querton, Benedicte, Riaz, Tawassal, Ross-Russell, Amy, Sanchez-Gonzalez, Amada, Wardle, Hayley, Warren, Sarah, Finn, Adam
Publicado 2022